PRESS RELEASE published on 09/20/2025 at 00:00, 6 months 29 days ago Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies Onco-Innovations announces manufacturing of nanoparticle formulation by Dalton Pharma Services to advance preclinical studies, enhancing clinical readiness in cancer research Cancer Research Preclinical Studies Onco-Innovations Nanoparticle Formulation Dalton Pharma Services
PRESS RELEASE published on 09/19/2025 at 23:19, 6 months 29 days ago RE Royalties Announces Cancellation of Previously Announced Non-Brokered Listed Issuer Financing Equity Offering Due to Early Repayment from Clients RE Royalties cancels private placement offering due to early loan repayments and share price volatility. Company well-capitalized for new opportunities and meeting bond maturity Renewable Energy Private Placement Loan Repayments RE Royalties Share Price Volatility
PRESS RELEASE published on 09/19/2025 at 22:35, 6 months 29 days ago Atlas Salt Issues Compensation Securities Atlas Salt Inc. grants 600,000 DSUs to its Board of Directors as part of the Equity Incentive Plan. The DSUs will vest in one year, subject to service conditions and regulatory requirements Board Of Directors DSUs Atlas Salt Inc. Regulatory Requirements Equity Incentive Plan
PRESS RELEASE published on 09/19/2025 at 22:12, 6 months 29 days ago Rapport Financier Semestriel 30 juin 2025
PRESS RELEASE published on 09/19/2025 at 22:10, 6 months 29 days ago GENFIT annonce l'arrêt de son programme VS-01 dans l'ACLF – le développement de VS-01 est recentré sur l'UCD GENFIT annonce l'arrêt de son programme VS-01 dans l'ACLF et se recentre sur l'UCD pour traiter les troubles du cycle de l'urée. L'arrêt fait suite à un événement indésirable grave dans l'essai clinique UNVEIL-IT® GENFIT ACLF VS-01 UCD Troubles Du Cycle De L'urée
PRESS RELEASE published on 09/19/2025 at 22:10, 6 months 29 days ago GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD GENFIT discontinues VS-01 program in ACLF and shifts focus to UCD due to safety concerns. The company aims to accelerate other assets in ACLF, while exploring CCA data and reducing operating expenses Clinical Trials GENFIT ACLF VS-01 UCD
PRESS RELEASE published on 09/19/2025 at 22:05, 6 months 29 days ago Core Silver Announces Closing of LIFE Flow-Through Private Placement Offering Core Silver Corp. closes $4.5M non-brokered private placement offering for exploration on Blue Property in Atlin, BC. Company to use funds on exploration expenses in Canada Exploration Private Placement Offering Blue Property Core Silver Corp. Atlin
PRESS RELEASE published on 09/19/2025 at 22:00, 6 months 29 days ago aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year CEO Rubino Di Girolamo extends contract at aap Implantate AG until 2028; COO Agnieszka Mierzejewska to leave in 2025. Company focuses on new antibacterial technology and strategic realignment COO CEO Aap Implantate AG Rubino Di Girolamo Agneiszka Mierzejewska
PRESS RELEASE published on 09/19/2025 at 22:00, 6 months 29 days ago One Scan, Two Proofs: SMX Exposes the Fatal Flaws in Recycling and Fire Safety SMX introduces groundbreaking technology embedding molecular markers for verifiable proof in plastics and fire safety. Collaboration with NAFRA to transform sustainability and ensure trust at the molecular level Sustainability Fire Safety SMX Molecular Markers NAFRA
PRESS RELEASE published on 09/19/2025 at 21:35, 6 months 29 days ago Moderna annonce la livraison des premiers vaccins à ARNm fabriqués au Canada aux provinces et territoires Moderna annonce la production des premiers vaccins à ARNm entièrement fabriqués au Canada, renforçant la capacité nationale de production. Collaboration pour la santé publique Canada Moderna Santé Publique Production Nationale Vaccin ARNm
Published on 04/18/2026 at 04:00, 1 day 5 hours ago Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Published on 04/18/2026 at 02:00, 1 day 7 hours ago AI/ML Innovations Announces Completion of Share Issuance
Published on 04/18/2026 at 01:35, 1 day 7 hours ago Medicure Announces Resignation of President and Chief Operating Officer
Published on 04/18/2026 at 01:00, 1 day 8 hours ago Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Published on 04/18/2026 at 00:00, 1 day 9 hours ago Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia
Published on 04/18/2026 at 00:05, 1 day 9 hours ago ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Published on 04/17/2026 at 21:39, 1 day 11 hours ago Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025
Published on 04/17/2026 at 20:33, 1 day 13 hours ago LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Published on 04/17/2026 at 19:30, 1 day 14 hours ago KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS
Published on 04/17/2026 at 20:30, 1 day 13 hours ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/17/2026 at 19:00, 1 day 14 hours ago Cegedim : Publication du Document d’Enregistrement Universel 2025
Published on 04/17/2026 at 19:00, 1 day 14 hours ago Cegedim: Release of its 2025 Universal Registration Document
Published on 04/17/2026 at 17:45, 1 day 15 hours ago Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Published on 04/17/2026 at 17:45, 1 day 15 hours ago Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın